XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net loss $ (25) $ (500) $ (2,468)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Net loss (gain) from securities transactions 52 (1,206) 926
Purchases of securities (2,985) (2,158) (1,945)
Proceeds from sales of securities 5,359 4,172 4,040
Payments to cover securities sold, not yet purchased (2,908) (2,775) (2,336)
Proceeds from securities sold, not yet purchased 3,836 4,025 2,913
Changes in receivables and payables relating to securities transactions (2,390) (2,035) (1,880)
Changes in derivative assets and liabilities (296) 321 (433)
Loss (Gain) on disposition of assets, net 8 (141) 17
Depreciation and amortization 509 517 510
Deferred taxes (148) (168) (49)
Inventory write-down 84 59 59
Other, net 72 50 12
Changes in other operating assets and liabilities:      
Accounts receivable, net (110) (110) 28
Inventories (180) (83) 147
Other assets (11) 24 30
Accounts payable 45 77 (162)
Accrued expenses and other liabilities 143 252 175
Net cash provided by (used in) operating activities 1,055 321 (416)
Cash flows from investing activities:      
Capital expenditures (338) (305) (199)
Turnaround expenditures (83) (5) (159)
Acquisition of businesses, net of cash acquired   (20) (8)
Purchases of investments     (337)
Proceeds from sale of investments 153 445 98
Proceeds from disposition of businesses and assets 4 414 25
Other, net 4 (1) (1)
Net cash (used in) provided by investing activities (260) 528 (581)
Cash flows from financing activities:      
Investment segment contributions from non-controlling interests (23) (5)  
Investment segment contributions from non-controlling interests 9 79 13
Partnership contributions 768 835 102
Partnership distributions (226) (134) (526)
Purchase of additional interests in consolidated subsidiaries (1)    
Dividends and distributions to non-controlling interests in subsidiaries (270) (101) (36)
Proceeds from Holding Company senior unsecured notes   1,214 866
Repayments of Holding Company senior unsecured notes (500) (1,205) (1,350)
Proceeds from subsidiary borrowings 115 1,165 1,946
Repayments of subsidiary borrowings (216) (1,545) (1,644)
Other, net   (10) (24)
Net cash (used in) provided by financing activities (344) 293 (653)
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents (1) 3 (4)
Net increase (decrease) in cash and cash equivalents and restricted cash and restricted cash equivalents 450 1,145 (1,654)
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period 4,436 3,291 4,945
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period $ 4,886 $ 4,436 $ 3,291